86 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
9 May 24
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
4:17pm
ongoing commitment to driving top-line revenues, controlling operating expenses, advancing our pipeline, and improving our capital structure,” said Denny
8-K
EX-2.1
n183bga xq
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K/A
EX-99.1
vla9xg8h6ureir 97
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K
EX-99.1
e3qh7bo
27 Oct 23
Regulation FD Disclosure
4:19pm
424B3
nyvudh
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
5paxtayn46
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
4sg l4qwo
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
yay2cx10eyeh5
16 Jun 23
Business combination disclosure
8:08am
425
pfqgg i7go849
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
y17wewvsss3tdo5
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
elc2o kwmn
18 May 23
Other Events
5:02pm